Icecure Medical Ltd Ord ICCM

$1.10 -0.03 (-2.65%)

Valuation

Market cap
3,769,000
Revenue TTM
$3,380,000
Net income TTM
$-15,060,000
PE ratio
0.00
Forward PE
—
Profit margin
-445.56%
Debt to equity
0.00

Trading

Volume
124,700
Avg volume
155,778
Day's range
$1.05 – $1.18
Shares out
3,426,000
Stochastic %K
8%
Beta
0.43
Analysts
Sell
Price target
$22.68

Price

Company profile

IceCure Medical Ltd, a commercial-stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors in the United States, Japan, India, China, Israel, and internationally. The company offers the ProSense system, a single probe cryoablation system for the treatment of malignant breast tumors, as well as its associated disposable...

Show more

IceCure Medical Ltd, a commercial-stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors in the United States, Japan, India, China, Israel, and internationally. The company offers the ProSense system, a single probe cryoablation system for the treatment of malignant breast tumors, as well as its associated disposables, including CryoProbes needles, and guiding needles/introducers; and IceSense3 system for ablation indications in urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MSense, a multi probe system for the treatment of multiple and larger tumors. The company serves hospitals, interventional radiological centers, ambulatory centers, and private clinics. IceCure Medical Ltd was incorporated in 2006 and is headquartered in Caesarea, Israel.

Industry
Medical Devices
Sector
Healthcare
Phone
972 4 623 0333
Website
https://www.icecure-medical.com
Address
7 Ha’Eshel St., PO Box 3163, Caesarea, Israel

Latest news